117 related articles for article (PubMed ID: 26722312)
1. Quantitative assessment of the effect of epidermal growth factor 61A/G polymorphism on the risk of hepatocellular carcinoma.
Shen XF; Zeng XT; Jian ZY; Zhou M; Zhou P; Zhang M
Oncol Lett; 2015 Nov; 10(5):3199-3205. PubMed ID: 26722312
[TBL] [Abstract][Full Text] [Related]
2. Association between epidermal growth factor gene +61A/G polymorphism and the risk of hepatocellular carcinoma: a meta-analysis based on 16 studies.
Jiang G; Yu K; Shao L; Yu X; Hu C; Qian P; Xie H; Li J; Zheng J; Zheng S
BMC Cancer; 2015 Apr; 15():314. PubMed ID: 25927412
[TBL] [Abstract][Full Text] [Related]
3. EGF +61A/G polymorphism contributes to increased gastric cancer risk: evidence from a meta-analysis.
Peng Q; Li S; Qin X; Lao X; Chen Z; Zhang X; Chen J
Cancer Cell Int; 2014; 14():134. PubMed ID: 25729328
[TBL] [Abstract][Full Text] [Related]
4. Lack of association between EGF +61A>G polymorphism and melanoma susceptibility in Caucasians: a HuGE review and meta-analysis.
Wu D; Wu Y; Zhang X; Cong P; Lv X
Gene; 2013 Feb; 515(2):359-66. PubMed ID: 23201894
[TBL] [Abstract][Full Text] [Related]
5. Genetic Polymorphism of Epidermal Growth Factor Gene as a Predictor of Hepatocellular Carcinoma in Hepatitis C Cirrhotic Patients.
Baghdadi I; Abu Ella K; El Shaaraway A; Elshayeb E; El-Rebey HS; El Hoseeny M; Naguib M; Nada A
Asian Pac J Cancer Prev; 2020 Jul; 21(7):2047-2053. PubMed ID: 32711431
[TBL] [Abstract][Full Text] [Related]
6. Association of the epidermal growth factor gene +61A>G polymorphism with hepatocellular carcinoma in an Iranian population.
Gholizadeh M; Khosravi A; Torabian P; Gholipoor N; Mansour Samaei N
Gastroenterol Hepatol Bed Bench; 2017; 10(4):284-288. PubMed ID: 29379593
[TBL] [Abstract][Full Text] [Related]
7. EGF +61A>G polymorphism and gastrointestinal cancer risk: a HuGE review and meta-analysis.
Piao Y; Liu Z; Ding Z; Xu L; Guo F; Sun Q; Xie X
Gene; 2013 Apr; 519(1):26-33. PubMed ID: 23403233
[TBL] [Abstract][Full Text] [Related]
8. Association between the risk of hepatitis virus-related hepatocellular carcinoma and EGF polymorphism: A PRISMA-compliant updated meta-analysis.
Wang Q; Xu L; Wu Q; Zhang M; Zhang J
Medicine (Baltimore); 2022 Oct; 101(42):e31280. PubMed ID: 36281156
[TBL] [Abstract][Full Text] [Related]
9. Association between cyclin D1 G870A polymorphism and hepatocellular carcinoma risk: a meta-analysis.
Luo T; Chen J; Liu JJ; Li H; You XM; Wang HL; Zhu SL; Li LQ
Onco Targets Ther; 2016; 9():4483-9. PubMed ID: 27499641
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor gene polymorphism 61A/G in patients with chronic liver disease for early detection of hepatocellular carcinoma: a pilot study.
Abbas E; Shaker O; Abd El Aziz G; Ramadan H; Esmat G
Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):458-63. PubMed ID: 22293333
[TBL] [Abstract][Full Text] [Related]
11. Epidermal growth factor 61A>G polymorphism is associated with risk of hepatocellular carcinoma: a meta-analysis.
Yang Z; Wu Q; Shi Y; Nie Y; Wu K; Fan D
Genet Test Mol Biomarkers; 2012 Sep; 16(9):1086-91. PubMed ID: 22852842
[TBL] [Abstract][Full Text] [Related]
12. Quantitative assessment of the association between +61A>G polymorphism of epidermal growth factor gene and susceptibility to glioma.
Tao Y; Liang G
Tumour Biol; 2014 Jan; 35(1):369-77. PubMed ID: 23963773
[TBL] [Abstract][Full Text] [Related]
13. Association between rs738409 polymorphism in patatin-like phospholipase domain-containing protein 3 (PNPLA3) gene and hepatocellular carcinoma susceptibility: Evidence from case-control studies.
Li JF; Zheng EQ; Xie M
Gene; 2019 Feb; 685():143-148. PubMed ID: 30403964
[TBL] [Abstract][Full Text] [Related]
14. Meta-analysis reveals an association between signal transducer and activator of transcription-4 polymorphism and hepatocellular carcinoma risk.
Zhang L; Xu K; Liu C; Chen J
Hepatol Res; 2017 Mar; 47(4):303-311. PubMed ID: 27126090
[TBL] [Abstract][Full Text] [Related]
15. Impacts of human leukocyte antigen DQ genetic polymorphisms and their interactions with hepatitis B virus mutations on the risks of viral persistence, liver cirrhosis, and hepatocellular carcinoma.
Ji X; Zhang Q; Li B; Du Y; Yin J; Liu W; Zhang H; Cao G
Infect Genet Evol; 2014 Dec; 28():201-9. PubMed ID: 25281206
[TBL] [Abstract][Full Text] [Related]
16. Genetic Polymorphism of Epidermal Growth Factor rs4444903 Influences Susceptibility to HCV-Related Liver Cirrhosis and Hepatocellular Carcinoma in a Chinese Han Population.
Zhang S; Qiao K; Trieu C; Huo Z; Dai Q; Du Y; Lu W; Hou W
Clin Lab; 2017 Apr; 63(4):845-850. PubMed ID: 28397482
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor-α 238 G/A polymorphism and risk of hepatocellular carcinoma: evidence from a meta-analysis.
Cheng K; Zhao YJ; Liu L; Wan JJ
Asian Pac J Cancer Prev; 2013; 14(5):3275-9. PubMed ID: 23803115
[TBL] [Abstract][Full Text] [Related]
18. Association between PNPLA3 rs738409 polymorphisms and risk of hepatocellular carcinoma and its development in patients with cirrhosis: a meta-analysis.
Zhang S; Wu H; Wu X; Lian W; Wang Y; Zhang X; Peng X
Int J Clin Exp Med; 2015; 8(5):6638-49. PubMed ID: 26221201
[TBL] [Abstract][Full Text] [Related]
19. Analysis of EGF+61A>G polymorphism and EGF serum levels in Brazilian glioma patients treated with perillyl alcohol-based therapy.
da Silveira Fd; Lopes Bde A; da Fonseca CO; Quirico-Santos T; de Palmer Paixão IC; de Amorim LM
J Cancer Res Clin Oncol; 2012 Aug; 138(8):1347-54. PubMed ID: 22481252
[TBL] [Abstract][Full Text] [Related]
20. Association between EGF +61A/G polymorphism and gastric cancer in Caucasians.
Araújo AP; Costa BM; Pinto-Correia AL; Fragoso M; Ferreira P; Dinis-Ribeiro M; Costa S; Reis RM; Medeiros R
World J Gastroenterol; 2011 Jan; 17(4):488-92. PubMed ID: 21274378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]